REFERENCES
Bell L, Williams L. (1979). Histochemical demonstration of alkaline
phosphatase in human intestine, normal and diseased. Histochemistry,
60(1), 85-89.
Bell MA, Scarrow WG. (1984). Staining for microvascular alkaline
phosphatase in thick celloidin sections of nervous tissue: Morphometric
and pathological applications. Microvasc Res, 27(2), 189-203.
HAGerstrand I, Lindholm K, Lindroth Y. (1976). Endothelial and Bile
Canalicular Alkaline Phosphatase in Human Liver and Serum. Scand J Clin
Lab Invest, 36(2), 131-135.
Hirschmugl B, Crozier S, Matthews N, Kitzinger E, Klymiuk I, Inskip HM
et al. (2018). Relation of placental alkaline phosphatase expression in
human term placenta with maternal and offspring fat mass. Int J Obes
(Lond), 42(6), 1202-1210.
Hui M, Tenenbaum HC. (1998). New face of an old enzyme: Alkaline
phosphatase may contribute to human tissue aging by inducing tissue
hardening and calcification. Anat Rec, 253(3), 91-94.
Hui M., Li SQ, Holmyard D, Cheng PT. (1997). Stable transfection of
nonosteogenic cell lines with tissue nonspecific alkaline phosphatase
enhances mineral deposition both in the presence and absence of
beta-glycerophosphate: possible role for alkaline phosphatase in
pathological mineralization. Calcif Tissue Int, 60(5), 467-472.
Jasper AE, McIver WJ, Sapey E, Walton, GM. (2019). Understanding the
role of neutrophils in chronic inflammatory airway disease. F1000Res
8(F1000 Faculty Rev), 557-574.
Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O,
Patel P et al. (2013). Intestinal alkaline phosphatase prevents
metabolic syndrome in mice. Proc Natl Acad Sci USA, 110(17), 7003-7008.
Kiffer-Moreira T, Sheen CR, Gasque KC, Bolean M, Ciancaglini P, van
Elsas A et al. (2014). Catalytic Signature of a Heat-Stable, Chimeric
Human Alkaline Phosphatase with Therapeutic Potentials. PLoS ONE, 9(2),
e89374.
Kovtun A, Messerer DAC, Scharffetter-Kochanek K, Huber-Lang M, Ignatius
A. (2018). Neutrophils in Tissue Trauma of the Skin, Bone, and Lung: Two
Sides of the Same Coin. J Immunol Res, 2018, 1-12.
Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. (2000). Extensive
troponin I and T modification detected in serum from patients with acute
myocardial infarction. Circulation, 102(11), 1221–1226.
Lalles JP. (2014). Luminal ATP:the missing link between intestinal
alkaline phosphatase, the gut microbiota, and inflammation?. Am J
Physiol Gastrointest Liver Physiol, 306(10), G824-G825.
Lukas M, Drastich P, Konecny M, Gionchetti P, Urban O, Cantoni F et al.
(2010). Exogenous alkaline phosphatase for the treatment of patients
with moderate to severe ulcerative colitis. Inflamm Bowel Dis, 16(7),
1180-1186.
Millan JL, Whyte MP. (2016). Alkaline phosphatase and hypophosphatasia.
Calcif. Tissue Int, 98(4), 398-416.
Mortaz E, Alipoor SD, Adcock IM, Mumby S, Koenderman L. (2018). Update
on Neutrophil Function in Severe Inflammation. Front Immunol, 9,
2171-2185.
Narisawa S, Huang L, Iwasaki A, Hasegawa H, Alpers DH, Millán JL.
(2003). Accelerated Fat Absorption in Intestinal Alkaline Phosphatase
Knockout Mice. Mol Cell Biol, 23(21), 7525-7530.
Peiseler M, Kubes P. (2019). More friend than foe: the emerging role of
neutrophils in tissue repair. J Clin Invest, 129(7), 2629-2639.
Peters E, Geraci S, Heemskerk S, Wilmer MJ, Bilos A, Kraenzlin B et al.
(2015). Alkaline phosphatase protects against renal inflammation through
dephosphorylation of lipopolysaccharide and adenosine triphosphate. Br J
Pharmacol, 172(20), 4932-4945.
Peters E, Mehta RL, Murray PT, Hummel J, Joannidis M, Kellum JA et al.
(2016a). Study protocol for a multicentre randomised controlled trial:
Safety, Tolerability, efficacy and quality of life of a human
recombinant alkaline Phosphatase in patients with sepsis-associated
Acute Kidney Injury (STOP-AKI). BMJ Open, 6(9), e012371.
Peters E, Heuberger J, Tiessen R, van Elsas A, Masereeuw R, Arend J et
al. (2016b). Pharmacokinetic Modeling and Dose Selection in a
Randomized, Double-Blind, Placebo-Controlled Trial of a Human
Recombinant Alkaline Phosphatase in Healthy Volunteers. Clin
Pharmacokinet, 55(10), 1227-1237.
Peters E, Stevens J, Arend J, Guan Z, Raaben W, Laverman P et al.
(2018). Biodistribution and translational pharmacokinetic modeling of a
human recombinant alkaline phosphatase. Int J Pharm, 495(1), 122-131.
Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DK. (1997). A
physiologic function for alkaline phosphatase: endotoxin detoxification.
Lab Invest, 76(3), 319-327.
Powell DR, Huttenlocher A. (2016). Neutrophils in the Tumor
Microenvironment. Trends Immunol, 37(1), 41-52.
Qian J, Wu H, Zhou X, Gao J, Zhao W, Aziz J et al. (2010).
A“GC-rich”method for mammalian gene expresion:a dominant role of
non-coding DNA GC content inregulation of mammalian gene expression. Sci
China Life Sci, 53(1), 94-100.
Schultz-Hector S, Balz K, Böhm M, Ikehara Y, Rieke L. (1993). Cellular
localization of endothelial alkaline phosphatase reaction product and
enzyme protein in the myocardium. J Histochem Cytochem, 41(12),
1813-1821.
Suzuki K. (2017). Exhaustive Exercise-Induced Neutrophil-Associated
Tissue Damage and Possibility of its Prevention. J Nanomedine
Biotherapeutic Discov, 07(02), 1000156.
Suzuki K. (2018). Involvement of neutrophils in exercise-induced muscle
damage and its modulation. Gen Int Med Clin Innov, 3(3), 1-8.
Trautmann A. (2009). Extracellular ATP in the Immune System: More Than
Just a ”Danger Signal”. Sci Signal, 2(56), pe6.
Williams AE, Chambers RC. (2016). Neutrophils and tissue damage: is
hypoxia the key to excessive degranulation. Thorax, 71(11), 977-978.
Wright HL, Moots RJ, Bucknall RC, Edwards SW. (2010). Neutrophil
function in inflammation and inflammatory diseases. Rheumatology
(Oxford), 49, 1618-1631.
Zhang CY, Dong X, Gao J, Lin W, Liu Z, Wang Z. (2019).
Nanoparticle-induced neutrophil apoptosis increases survival in sepsis
and alleviates neurological damage in stroke. Sci Adv, 5(11), 2375-2548.